British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus RC Fitzgerald, M Di Pietro, K Ragunath, Y Ang, JY Kang, P Watson, ... Gut 63 (1), 7-42, 2014 | 1527 | 2014 |
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study NA Kennedy, GA Heap, HD Green, B Hamilton, C Bewshea, GJ Walker, ... The lancet Gastroenterology & hepatology 4 (5), 341-353, 2019 | 586 | 2019 |
HLA-DQA1* 05 carriage associated with development of anti-drug antibodies to infliximab and adalimumab in patients with Crohn’s disease A Sazonovs, NA Kennedy, L Moutsianas, GA Heap, DL Rice, M Reppell, ... Gastroenterology 158 (1), 189-199, 2020 | 314 | 2020 |
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial JAZ Jankowski, J De Caestecker, SB Love, G Reilly, P Watson, S Sanders, ... The Lancet 392 (10145), 400-408, 2018 | 266 | 2018 |
Meta analysis: cancer risk in Barrett’s oesophagus T Thomas, KR Abrams, JS De Caestecker, RJ Robinson Alimentary pharmacology & therapeutics 26 (11‐12), 1465-1477, 2007 | 213 | 2007 |
Common variants at the MHC locus and at chromosome 16q24. 1 predispose to Barrett's esophagus Esophageal Adenocarcinoma Genetics Consortium, ... Nature genetics 44 (10), 1131-1136, 2012 | 209 | 2012 |
Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis P Gharahkhani, RC Fitzgerald, TL Vaughan, C Palles, I Gockel, ... The lancet oncology 17 (10), 1363-1373, 2016 | 183 | 2016 |
Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett’s oesophagus: factors determining persistence and recurrence of Barrett’s epithelium KK Basu, B Pick, R Bale, KP West, JS De Caestecker Gut 51 (6), 776-780, 2002 | 183 | 2002 |
Determinants of pregnancy heartburn JM Marrero, PM Goggin, JS De Caestecker, JM Pearce, JD Maxwell BJOG: An International Journal of Obstetrics & Gynaecology 99 (9), 731-734, 1992 | 173 | 1992 |
Daytime gastro-oesophageal reflux is important in oesophagitis. JS De Caestecker, JN Blackwell, A Pryde, RC Heading Gut 28 (5), 519-526, 1987 | 166 | 1987 |
The oesophagus as a cause of recurrent chest pain: which patients should be investigated and which tests should be used? JS De Caestecker, J Brown, JN Blackwell, RC Heading The Lancet 326 (8465), 1143-1146, 1985 | 155 | 1985 |
Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid RP Jazrawi, JS De Caestecker, PM Goggin, AJ Britten, AEA Joseph, ... Gastroenterology 106 (1), 134-142, 1994 | 153 | 1994 |
UK guidelines on oesophageal dilatation in clinical practice SS Sami, HN Haboubi, Y Ang, P Boger, P Bhandari, J De Caestecker, ... Gut 67 (6), 1000-1023, 2018 | 139 | 2018 |
Sensitization to painful distention and abnormal sensory perception in the esophagus AJ Mehta, JS De Caestecker, AJ Camm, TC Northfield Gastroenterology 108 (2), 311-319, 1995 | 112 | 1995 |
Prevalence of inflammatory bowel disease in patients with airways disease AA Raj, SS Birring, R Green, A Grant, J De Caestecker, ID Pavord Respiratory medicine 102 (5), 780-785, 2008 | 93 | 2008 |
Barium radiology: a sensitive test for gastro-oesophageal reflux RJ Sellar, JS De Caestecker, RC Heading Clinical radiology 38 (3), 303-307, 1987 | 87 | 1987 |
British Society of Gastroenterology guidelines for oesophageal manometry and oesophageal reflux monitoring NJ Trudgill, D Sifrim, R Sweis, M Fullard, K Basu, M McCord, M Booth, ... Gut 68 (10), 1731-1750, 2019 | 86 | 2019 |
Clinical value of radionuclide oesophageal transit measurement. JS De Caestecker, JN Blackwell, RD Adam, WJ Hannan, J Brown, ... Gut 27 (6), 659-666, 1986 | 78 | 1986 |
Ursodeoxycholic acid in chronic liver disease. JS De Caestecker, RP Jazrawi, ML Petroni, TC Northfield Gut 32 (9), 1061-1065, 1991 | 77 | 1991 |
Esophageal pH monitoring JS De Caestecker, RC Heading Gastroenterology Clinics of North America 19 (3), 645-669, 1990 | 70 | 1990 |